scholarly journals Antibiotic Utilization Trends in Two State Hospitals of Mongolia from 2013 to 2017

2019 ◽  
Vol 2019 ◽  
pp. 1-8
Author(s):  
Gereltuya Dorj ◽  
Hege Salvesen Blix ◽  
Bruce Sunderland ◽  
Badamkhand Gankhulug ◽  
Otgonbileg Tegshee ◽  
...  

Background. The study aimed to evaluate inpatient antibiotic use in both the State Second Hospital and State Third Hospital in Mongolia, using the WHO developed and standardized ATC/DDD methodology. Methods. Data were collected from the State Second Hospital and State Third Hospital which are major public hospitals that provide health care for approximately one fifth of the Mongolian population. Antibiotic utilization was monitored retrospectively for five years (2013–2017) using the ATC/DDD methodology and data were presented in DDD/ admission and DDD/100 bed days. Statistical analysis was performed using a Student’s t-test for parametric data. A P value of ≤0.05 was considered to be statistically significant. Results. The annual consumption rates in the State Second Hospital were stable over time while in the State Third Hospital consumption rates varied considerately between years. Overall, the total antibiotic consumption rate was very high, but has decreased in both hospitals. The rate of consumption of all antibiotics was approximately twice that in the State Third Hospital (421.7 DDD/100 bed days) between 2013 and 2017 when compared with the State Second Hospital (199.7 DDD/ 100 bed days), P<0.001). The seven most frequently used antibiotics comprised approximately 75% of all DDDs in both hospitals, in the period 2013–2017; being: amoxicillin, cefazolin, cefotaxime, ceftriaxone, clarithromycin, ciprofloxacin, and nitroxoline. However, this was not consistent when considering the individual years, since in 2015 and 2016, these seven active agents represented approximately 50%. Conclusion. This is the first hospital-based study of antibiotic consumption rates reported in Mongolia. In addition to very high consumption rates, large differences occurred between the hospitals investigated. Inappropriate and high levels of antibiotic use lead to increased costs and also increased nosocomial infection rates with potentially resistant species. The Government and health professionals need to take more active roles in improving and promoting quality antibiotic use among inpatients.

Author(s):  
Zamharira Muslim

Objective: The aim of this study was to evaluate the utilization of antibiotics for children in the General Hospital of Dr. M. Yunus Bengkulu, Indonesia by using the ATC/DDD index, which is accepted as a standard method.Methods: This study was descriptive analytic research with qualitative methods. Observations conducted over six months collecting retrospective prescribing data antibiotics in children admitted in January to June 2014. Data obtained assessed antibiotics prescribed in a quantity which is calculated using ATC/DDD index. In this study, DDDs of anti-infective agents are listed for systemic use, according to ATC/DDD 2016 Index. Data pediatric patients hospitalized amounted to 447 patients while fulfilling the inclusion criteria amounted to 103 medical records and the use of antibiotics which recorded 175 prescriptions.Results: The kind of antibiotics that are widely used are gentamicin (34.9%) and ampicillin (34.3%). The highest ACI based group is penicillin group antibiotics (ampicillin) is 26 DDD/100 bed-days. Highest DDDs in this study is ampicillin (101.7). Utilization of antibiotics in hospitals in Bengkulu, Indonesia to pediatric patient higher than suggested by the WHO is based on a quantitative analysis using the ACT/DDD index.Conclusion: Analysis of antibiotic use in children is not rationally quantitatively seen from the total value of ACI in one of the government hospital is very high compared to WHO standard and based on the most antibiotic type was ampicillin followed by gentamicin.


Author(s):  
Franka Lestin-Bernstein ◽  
Ramona Harberg ◽  
Ingo Schumacher ◽  
Lutz Briedigkeit ◽  
Oliver Heese ◽  
...  

Abstract Background Antimicrobial stewardship (AMS) strategies worldwide focus on optimising the use of antibiotics. Selective susceptibility reporting is recommended as an effective AMS tool although there is a lack of representative studies investigating the impact of selective susceptibility reporting on antibiotic use. The aim of this study was to investigate the impact of selective susceptibility reporting of Staphylococcus aureus (S. aureus) on antibiotic consumption. Enhancing the use of narrow-spectrum beta-lactam antibiotics such as flucloxacillin/cefazolin/cefalexin is one of the main goals in optimising antibiotic therapy of S. aureus infections. Methods This interventional study with control group was conducted at a tertiary care hospital in Germany. During the one-year interventional period susceptibility reports for all methicillin-sensitive S. aureus (MSSA) were restricted to flucloxacillin/cefazolin/cefalexin, trimethoprim-sulfamethoxazole, clindamycin, gentamicin and rifampin/fosfomycin, instead of reporting all tested antibiotics. The impact of implementing selective reporting was analysed by monitoring total monthly antibiotic consumption in our hospital and in a reference hospital (recommended daily dose/100 occupied bed days: RDD/100 BD), as well as on an individual patient level by analysing days of therapy adjusted for bed days (DOT/ 100 BD) for patients with S. aureus bacteremia (SAB) and respectively skin and soft tissue infections (SSTI). Results MSSA-antibiograms were acquired for 2836 patients. The total use of narrow-spectrum beta-lactams more than doubled after implementing selective reporting (from 1.2 to 2.8 RDD/100 BD, P < 0.001). The use of intravenous flucloxacillin/cefazolin for SAB rose significantly from 52 to 75 DOT/100 BD (plus 42%), just as the use of oral cefalexin for SSTI (from 1.4 to 9.4 DOT/100 BD, from 3 to 17 of 85/88 patients). Considering the overall consumption, there was no decrease in antibiotics omitted from the antibiogram. This was probably due to their wide use for other infections. Conclusions As narrow-spectrum beta-lactams are not widely used for other infections, their increase in the overall consumption of the entire hospital was a strong indicator that selective reporting guided clinicians to an optimised antibiotic therapy of S. aureus infections. On a patient level, this assumption was verified by a significant improved treatment of S. aureus infections in the subgroups of SAB and SSTI. As useful AMS tool, we recommend implementing selective reporting rules into the national/international standards for susceptibility reporting.


2016 ◽  
Vol 21 (32) ◽  
Author(s):  
Ajay Oza ◽  
Fionnuala Donohue ◽  
Howard Johnson ◽  
Robert Cunney

As antibiotic consumption rates between hospitals can vary depending on the characteristics of the patients treated, risk-adjustment that compensates for the patient-based variation is required to assess the impact of any stewardship measures. The aim of this study was to investigate the usefulness of patient-based administrative data variables for adjusting aggregate hospital antibiotic consumption rates. Data on total inpatient antibiotics and six broad subclasses were sourced from 34 acute hospitals from 2006 to 2014. Aggregate annual patient administration data were divided into explanatory variables, including major diagnostic categories, for each hospital. Multivariable regression models were used to identify factors affecting antibiotic consumption. Coefficient of variation of the root mean squared errors (CV-RMSE) for the total antibiotic usage model was very good (11%), however, the value for two of the models was poor (> 30%). The overall inpatient antibiotic consumption increased from 82.5 defined daily doses (DDD)/100 bed-days used in 2006 to 89.2 DDD/100 bed-days used in 2014; the increase was not significant after risk-adjustment. During the same period, consumption of carbapenems increased significantly, while usage of fluoroquinolones decreased. In conclusion, patient-based administrative data variables are useful for adjusting hospital antibiotic consumption rates, although additional variables should also be employed.


Author(s):  
Yasser M. Kazzaz ◽  
Haneen AlTurki ◽  
Lama Aleisa ◽  
Bashaer Alahmadi ◽  
Nora Alfattoh ◽  
...  

Abstract Background Inappropriate antibiotic utilization is associated with the emergence of antimicrobial resistance (AMR) and a decline in antibiotic susceptibility in many pathogenic organisms isolated in intensive care units. Antibiotic stewardship programs (ASPs) have been recommended as a strategy to reduce and delay the impact of AMR. A crucial step in ASPs is understanding antibiotic utilization practices and quantifying the problem of inappropriate antibiotic use to support a targeted solution. We aim to characterize antibiotic utilization and determine the appropriateness of antibiotic prescription in a tertiary care pediatric intensive care unit. Methods A retrospective cohort study was conducted at King Abdullah Specialized Children’s Hospital, Riyadh, Saudi Arabia, over a 6-month period. Days of therapy (DOT) and DOT per 1000 patient-days were used as measures of antibiotic consumption. The appropriateness of antibiotic use was assessed by two independent pediatric infectious disease physicians based on the Centers for Disease Control and Prevention 12-step Campaign to prevent antimicrobial resistance among hospitalized children. Results During the study period, 497 patients were admitted to the PICU, accounting for 3009 patient-days. A total of 274 antibiotic courses were administered over 2553 antibiotic days. Forty-eight percent of antibiotic courses were found to be nonadherent to at least 1 CDC step. The top reasons were inappropriate antibiotic choice (empirical or definitive) and inappropriate prophylaxis durations. Cefazolin and vancomycin contributed to the highest percentage of inappropriate DOTs. Conclusions Antibiotic consumption was high with significant inappropriate utilization. These data could inform decision-making in antimicrobial stewardship programs and strategies. The CDC steps provide a more objective tool and limit biases when assessing antibiotic appropriateness


2020 ◽  
Author(s):  
Yasser M Kazzaz ◽  
Haneen AlTurki ◽  
Lama Aleisa ◽  
Bashaer Alahmadi ◽  
Nora Alfattoh ◽  
...  

Abstract Background: Inappropriate antibiotic utilization is associated with the emergence of antimicrobial resistance (AMR) and a decline in antibiotic susceptibility in many pathogenic organisms isolated in intensive care units. Antibiotic stewardship programs (ASPs) have been recommended as a strategy to reduce and delay the impact of AMR. A crucial step in ASPs is understanding antibiotic utilization practices and quantifying the problem of inappropriate antibiotic use to support a targeted solution. We aim to characterize antibiotic utilization and determine the appropriateness of antibiotic prescription in a tertiary care pediatric intensive care unit.Methods: A retrospective cohort study was conducted at King Abdullah Specialized Children’s Hospital (KASCH), Riyadh, Saudi Arabia, over a 6-month period. Days of therapy (DOT) and DOT per 1000 patient-days were used as measures of antibiotic consumption. The appropriateness of antibiotic use was assessed by two independent pediatric infectious disease physicians based on the Centers for Disease Control and Prevention 12-step Campaign to Prevent Antimicrobial Resistance Among Hospitalized Children.Results: During the study period, 497 patients were admitted to the PICU, accounting for 3009 patient-days. A total of 274 antibiotic courses were administered over 2553 antibiotic days. Forty-eight percent of antibiotic courses were found to be nonadherent to at least 1 CDC step. The top reasons were inappropriate antibiotic choice (empirical or definitive) and inappropriate prophylaxis durations. Cefazolin and vancomycin contributed to the highest percentage of inappropriate DOTs.Conclusions: Antibiotic consumption was high with significant inappropriate utilization. These data could inform decision-making in antimicrobial stewardship programs and strategies. The CDC steps provide a more objective tool and limit biases when assessing antibiotic appropriateness


2020 ◽  
Vol 7 (11) ◽  
pp. 249-258
Author(s):  
Tatjana Pokrajac ◽  
Milan Čižman ◽  
Bojana Beovič

Abstract: Motivation/Background: Antibiotics are commonly overused and misused what increase the emergence of resistant organisms, side- effects and costs. To assess the appropriate use of antibiotics many methods are available. The aim of the present study is to find correlation between antibiotic use and case mix index (CMI) in Slovenian hospitals. Method: In retrospective study (in the years between 2004 and 2013) we correlated the total consumption of antibiotics for systemic use and CMI. Weighted linear regression test analysis was performed to determine correlation between defined daily dose (DDD) / 100 admissions and DDD / 100 bed-days and CMI. Results: The total antibiotic consumption in all included hospitals was in mean 317.69 DDD / 100 admissions and 58.88 DDD / 100 bed days, respectively. CMI range were from 1.25 to 3.55. A significant correlation between consumption expressed in DDD / 100 admissions and CMI (p = 0.028) and DDD / 100 bed days and CMI (p =0.008) was found. Conclusions: Thus, detailed analysis of correlations between DDD of antibiotics and CMI may constitutes a proper use of antibiotics.


Author(s):  
Sen Xu ◽  
Shengfang Yuan ◽  
John Alimamy Kabba ◽  
Chen Chen ◽  
Wenchen Liu ◽  
...  

Overuse of antibiotics has caused a series of global problems, especially in the underdeveloped western regions where healthcare systems are fragile. We used antibiotic procurement data of all healthcare institutions to analyze the total amount, patterns and trends of antibiotic use in Shaanxi Province, western China between 2015 and 2018. Antibiotic utilization was quantified using the standard Anatomical Therapeutic Chemical (ATC)/Defined daily dose (DDD) methodology. The World Health Organization’s “Access, Watch and Reserve” (AWaRe) classification and European Surveillance of Antimicrobial Consumption (ESAC) drug-specific quality indicators were also adopted to evaluate the appropriateness and quality of antibiotic utilization. Overall, antibiotic consumption decreased from 11.20 DID in 2015 to 10.13 DID (DDDs per 1000 inhabitants per day) in 2016, then increased to 12.99 DID in 2018. The top three antibiotic categories consumed in 2018 were J01C (penicillins) 33.58%, J01D (cephalosporins) 29.76%, and J01F (macrolides) 19.14%. Parenteral antibiotics accounted for 27.41% of the total consumption. The largest proportion of antibiotic use was observed in primary healthcare institutions in rural areas, which accounts for 51.67% of total use. Consumption of the Access group, the Watch group, the Reserve group of antibiotics was 40.31%, 42.28% and 0.11%, respectively. Concurrently, the consumption of J01D and the percentage of J01 (DD + DE) (third and fourth generation cephalosporins) were at a poor level according to the evaluation of ESAC quality indicators. The total antibiotic consumption in Shaanxi Province had been on an upward trend, and the patterns of antibiotic use were not justified enough to conclude that it was rational. This is partly because there was high preference for the third and fourth generation cephalosporins and for the Watch group antibiotics.


2017 ◽  
Vol 6 (4) ◽  
pp. 68-69
Author(s):  
P R Shankar ◽  
R M Piryani ◽  
S Piryani

 Antibiotics play an important role in modern healthcare and the modern medical system is dangerously and solely dependent on them to fight and prevent infections. Antimicrobial resistance (AMR) is however, becoming increasingly common with the injudicious use of antibiotics being one of the common reasons. AMR is now attracting attention both in the lay and the scientific press and the grim possibility of a world without antibiotics is being visualized. The Center for Disease Dynamics, Economics and Policy, Washington DC, United States of America (USA) has recently published a report on the state of the world’s antibiotics. Eight working groups of the Global Antibiotic Resistance Partnership (GARP), one each from India, Kenya, Mozambique, Nepal, South Africa, Tanzania, Uganda, and Vietnam have contributed to the report and Hellen Gelband, Molly Miller-Petrie, Suraj Pant, Sumanth Gandra, Jordan Levinson, Devra Barter, Andrea White and Ramanan Laxminarayan have authored the report.The authors of the report mention that two factors are driving the world’s increased requirement for antibiotics. Rising incomes is increasing access to antibiotics and an increased demand for animal protein is resulting in intensification of agriculture and animal husbandry with a greater potential for antibiotic use. The book briefly mentions the tool, Resistance Map which brings together AMR statistics from a number of nations. There has been a huge increase in antibiotic consumption in livestock especially among developing nations.Chapter 1 discusses antibiotic resistance in 2015. Methicillin-resistant Staphylococcus aureus (MRSA), extended-spectrum beta-lactamase producers (ESBL), carbapenem-resistant enterobacteriaceae, are among the major organisms described and resistance is increasing among nearly all micro-organisms. Different countries have or are in the process of setting up AMR surveillance systems which are briefly described in the book.Chapter 2 focuses on human use of antibiotics. Globally the consumption of the two groups of ‘last resort’ antibiotics, carbapenems and polymixins has been rising. As mentioned previously the developing world has been witnessing huge increases in antibiotic consumption. The table showing public campaigns to improve use of antibiotics among outpatients provides an overview of important campaigns. Antibiotics in agriculture and the environment is the focus of chapter 3. Antibiotic use in agriculture is greater than their use among humans. Regulating antibiotic use in agriculture and animal husbandry is becoming a priority area globally.Antibiotics lose effectiveness over time and the report mentions how each new generation of antibiotics has proven exponentially more expensive than its precursors. Issues of antibiotic quality (substandard and counterfeit medicines) persist in many areas of the world and reintroduction of older antibiotics could be an option as bacteria ‘forget’ about antibiotics which are not in common use.Chapter 4 mentions about 1) the stewardship and effective public health measures contributing towards a decline in the use of antibiotics, and hence antibiotic resistance, 2) feasible and practicable interventions that could contribute in maintaining antibiotic effectiveness and 3) alternative and complementary approaches applied to control and treat infections.Vaccines could be an important initiative to reduce antibiotic use. It also describes the six strategies that contribute to slowing resistance and maintaining the effectiveness of current drugs.Excellent maps and tables add to the information presented in the book. High production standards and effective use of color characterize this well-written and presented report. The list of references provided at the end of the book is comprehensive and will be of interest to readers interested in knowing more about the issues discussed. This book will be of interest to specialists in the field of AMR and to health professionals interested in preserving the power of antibiotics for future generations. The technical language used may make reading the book difficult for lay persons but those interested can still do so.About the book: Center for Disease Dynamics, Economics & Policy. 2015. State of the World’s Antibiotics, 2015. CDDEP: Washington, D.C. The report is freely available at http://cddep.org/publications/ state_worlds_antibiotics_2015#sthash.RKLp0pcM. dpbs and can be downloaded for free from https:// cddep.org/sites/default/files/swa_2015_final.pdf  


2019 ◽  
Vol 7 (2) ◽  
pp. 81-87
Author(s):  
Taradharani Wikantiananda ◽  
Adi Imam Tjahjadi ◽  
Reza Widianto Sudjud

Objective: To find out the pattern of antibiotic utilization in intensive care unit (ICU). The high use of antibiotics in intensive care may increase antibiotic resistance. Methods: This was a retrospective study with total sampling method from patients who were treated in ICU in the period of January to June 2016. Selected data is processed using the Anatomical Therapeutic Chemical (ATC) Classification/Defined Daily Dose (DDD) system as an international measurement standard for analyzing and comparing usage applied by the WHO. Results: The results showed that of the 57 medical records collected, the total antibiotic use was 295.72 DDD/100 bed-days. Levofloxacin, meropenem, ceftriaxone, ceftazidime, and metronidazole were the five maximally utilized antibiotics with 143.18, 49.88, 30.62, 19.74, dan 16.99 DDD/100 bed-days respectively. Conclusion: The most frequently used of antibiotics is ceftriaxone, used in 54.39% of patients. Whereas in number, the most widely used antibiotic is levofloxacin with a total of 143.18 DDD/100 bed-days.


Author(s):  
Elīna Dimiņa ◽  
Mārtiņš Akermanis ◽  
Uga Dumpis

Antibiotic Consumption in the Latvian Teaching Hospital 2000-2008 Antibiotics are one of the most commonly used drugs in hospital care and significantly contribute to healthcare costs. Recently, there has been significant interest raised on the environmental impact of antibiotic use, in particular on how it effects resistance selection pressure. Rapid global spread of multiresistant bacteria requires improved understanding on how changes in antibiotic use affect resistance selection. We present a unique study on antibiotic consumption and its trends over an eight-year period. Data were obtained from the pharmaceutical database system. The study period extended from January 2000 through December 2008. Antibiotic use was expressed as a rate — defined daily doses (DDD) per 100 patient days (DDD/100) in a quarter year. The total amount of antibiotics used for systemic treatment at the beginning of the period (first quarter of 2000) was 38.7 DDD per 100 bed days and increased to 72.6 DDD per 100 bed days (r = 0.81) by the 4th quarter of 2008. Despite variability during the study period, a significant trend was observed with an average increase of 0.97 (95% CI: 1.2; 3.2) per quarter. Penicillin was the most common antibiotic group used at the hospital in the study period and demonstrated the greatest increase in consumption (r = 0.92). The consumption rates of fluoroquinolones were high and also showed a significant increase (r = 0.76). We observed a significant increase of antibiotic consumption in our hospital during the study period, which lacked a clear explanation. This increase was mostly due to increased use of amoxicillinum/enzyme inhibitor and ceftriaxone. Analysis of consumption should be continued to assess the impact of educational interventions.


Sign in / Sign up

Export Citation Format

Share Document